01126nas a2200217   4500000000100000008004100001260001200042100001300054700001500067700001500082700001400097700001600111700001300127700001200140700001500152700001000167700001700177245008400194520061600278022001400894       2021                            d  c03/20211 aRundle C1 aFortugno A1 aMaghfour J1 aPresley C1 aPulsipher K1 aHusayn S1 aNaldi L1 aChosidow O1 aHay R1 aDellavalle R00aEvaluating World Health Organization Essential Medicines List for Skin Disease.3 a<p>Skin diseases comprise nearly 2% of all health burden and are the 4 leading cause of non-fatal disease globally. To address such needs, the World Health Organization List of Essential Medicines (WMLEM) aims to meet the basic needs of global communities by recommending effective, cost-efficient therapies. While an inherently difficult task, disparities are noted in the WMLEM. Herein, this letter utilizes Global Burden of Disease (GBD), Treatment of Skin Disease (5 edition) (TSD), and Evidence-Based Dermatology (3 edition) (EBD) data, and expert opinion to explore the paucities of the current WMLEM.</p>  a1365-2133